Eli Lilly (LLY) Dividends payables Growth (1y) (2010 - 2025)

Eli Lilly (LLY) Dividends payables Growth (1y) (2010 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 14.93%
Dec 31, 2024 15.15%
Jun 30, 2024 15.18%
Dec 31, 2023 14.94%
Jun 30, 2023 15.19%
Dec 31, 2022 14.87%
Jun 30, 2022 14.45%
Dec 31, 2021 14.91%
Dec 31, 2020 14.76%
Dec 31, 2019 3.18%
Jun 30, 2019 2.72%
Dec 31, 2018 10.19%
Jun 30, 2018 5.61%
Dec 31, 2017 7.75%
Jun 30, 2017 1.86%
Dec 31, 2016 1.69%
Jun 30, 2016 1.57%
Dec 31, 2015 1.64%
Jun 30, 2015 0.97%
Dec 31, 2014 1.30%